These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 17523078)
1. Frequent intra-tumoural heterogeneity of promoter hypermethylation in malignant melanoma. Rastetter M; Schagdarsurengin U; Lahtz C; Fiedler E; Marsch WCh; Dammann R; Helmbold P Histol Histopathol; 2007 Sep; 22(9):1005-15. PubMed ID: 17523078 [TBL] [Abstract][Full Text] [Related]
2. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions. Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681 [TBL] [Abstract][Full Text] [Related]
3. Aberrant promoter methylation in pleural fluid DNA for diagnosis of malignant pleural effusion. Katayama H; Hiraki A; Aoe K; Fujiwara K; Matsuo K; Maeda T; Murakami T; Toyooka S; Sugi K; Ueoka H; Tanimoto M Int J Cancer; 2007 May; 120(10):2191-5. PubMed ID: 17285579 [TBL] [Abstract][Full Text] [Related]
4. Azacytidine inhibits the proliferation of human promyelocytic leukemia cells (HL60) by demethylation of MGMT, DAPK and p16 genes. Su Y; Xu H; Xu Y; Yu J; Xian Y; Luo Q Hematology; 2012 Jan; 17(1):41-6. PubMed ID: 22549447 [TBL] [Abstract][Full Text] [Related]
5. Detecting methylation patterns of p16, MGMT, DAPK and E-cadherin genes in multiple myeloma patients. Yuregir OO; Yurtcu E; Kizilkilic E; Kocer NE; Ozdogu H; Sahin FI Int J Lab Hematol; 2010 Apr; 32(2):142-9. PubMed ID: 19302404 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of epigenetic inactivation of p16, p15, MGMT and DAPK genes in follicular lymphoma. Krajnović M; Radojković M; Davidović R; Dimitrijević B; Krtolica K Med Oncol; 2013 Mar; 30(1):441. PubMed ID: 23275143 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of DAPK and RASSF1A promoter hypermethylation in non-small cell lung cancer (NSCLC). Niklinska W; Naumnik W; Sulewska A; Kozłowski M; Pankiewicz W; Milewski R Folia Histochem Cytobiol; 2009; 47(2):275-80. PubMed ID: 19926549 [TBL] [Abstract][Full Text] [Related]
8. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only. De Schutter H; Geeraerts H; Verbeken E; Nuyts S Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529 [TBL] [Abstract][Full Text] [Related]
9. Correlation between promoter hypermethylation of GSTP1 and response to chemotherapy in diffuse large B cell lymphoma. Nakamichi I; Tomita Y; Zhang B; Sugiyama H; Kanakura Y; Fukuhara S; Hino M; Kanamaru A; Ogawa H; Aozasa K Ann Hematol; 2007 Aug; 86(8):557-64. PubMed ID: 17508213 [TBL] [Abstract][Full Text] [Related]
10. Comparison of promoter hypermethylation pattern in salivary rinses collected with and without an exfoliating brush from patients with HNSCC. Sun W; Zaboli D; Liu Y; Arnaoutakis D; Khan T; Wang H; Koch W; Khan Z; Califano JA PLoS One; 2012; 7(3):e33642. PubMed ID: 22438973 [TBL] [Abstract][Full Text] [Related]
11. Aberrant promoter methylation of CDH13 and MGMT genes is associated with clinicopathologic characteristics of primary non-small-cell lung carcinoma. Kontic M; Stojsic J; Jovanovic D; Bunjevacki V; Ognjanovic S; Kuriger J; Puumala S; Nelson HH Clin Lung Cancer; 2012 Jul; 13(4):297-303. PubMed ID: 22169480 [TBL] [Abstract][Full Text] [Related]
12. Promoter methylation of p16INK4a, RASSF1A, and DAPK is frequent in salivary adenoid cystic carcinoma. Li J; El-Naggar A; Mao L Cancer; 2005 Aug; 104(4):771-6. PubMed ID: 15959912 [TBL] [Abstract][Full Text] [Related]
13. Correlation of promoter hypermethylation in hTERT, DAPK and MGMT genes with cervical oncogenesis progression. Iliopoulos D; Oikonomou P; Messinis I; Tsezou A Oncol Rep; 2009 Jul; 22(1):199-204. PubMed ID: 19513524 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of tumor-related genes hypermethylation detected in cancer-free surgical margins of oral squamous cell carcinomas. Supic G; Kozomara R; Jovic N; Zeljic K; Magic Z Oral Oncol; 2011 Aug; 47(8):702-8. PubMed ID: 21697000 [TBL] [Abstract][Full Text] [Related]
15. Multiplicity of abnormal promoter methylation in lung adenocarcinomas from smokers and never smokers. Divine KK; Pulling LC; Marron-Terada PG; Liechty KC; Kang T; Schwartz AG; Bocklage TJ; Coons TA; Gilliland FD; Belinsky SA Int J Cancer; 2005 Apr; 114(3):400-5. PubMed ID: 15578700 [TBL] [Abstract][Full Text] [Related]
16. PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients. Buckingham L; Penfield Faber L; Kim A; Liptay M; Barger C; Basu S; Fidler M; Walters K; Bonomi P; Coon J Int J Cancer; 2010 Apr; 126(7):1630-9. PubMed ID: 19795445 [TBL] [Abstract][Full Text] [Related]
17. Similar DNA methylation pattern in lung tumours from smokers and never-smokers with second-hand tobacco smoke exposure. Scesnaite A; Jarmalaite S; Mutanen P; Anttila S; Nyberg F; Benhamou S; Boffetta P; Husgafvel-Pursiainen K Mutagenesis; 2012 Jul; 27(4):423-9. PubMed ID: 22217548 [TBL] [Abstract][Full Text] [Related]
18. Promoter methylation as biomarkers for diagnosis of melanoma: A systematic review and meta-analysis. Guo Y; Long J; Lei S J Cell Physiol; 2019 May; 234(5):7356-7367. PubMed ID: 30370527 [TBL] [Abstract][Full Text] [Related]
19. An inverse correlation between Interleukin-6 and select gene promoter methylation in patients with gastric cancer. Tang LP; Cho CH; Hui WM; Huang C; Chu KM; Xia HH; Lam SK; Rashid A; Wong BC; Chan AO Digestion; 2006; 74(2):85-90. PubMed ID: 17139167 [TBL] [Abstract][Full Text] [Related]
20. Promoter methylation of p16, Runx3, DAPK and CHFR genes is frequent in gastric carcinoma. Hu SL; Kong XY; Cheng ZD; Sun YB; Shen G; Xu WP; Wu L; Xu XC; Jiang XD; Huang DB Tumori; 2010; 96(5):726-33. PubMed ID: 21302620 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]